Author

Serey C.L. Nouth

Observed names: S. C. Nouth, Serey Nouth

Institutions: Stanford Medicine, Stanford University

Observed institutions: Stanford Medicine, University of California, Berkeley, Stanford University

ORCID: 0009-0007-3075-0223

Observed ORCID: 0009-0007-3075-0223

OpenAlex ID: A5115870872

Genomic characterization of Pseudomonas syringae pv. syringae from Callery pear and the efficiency of associated phages in disease protection

2024 · D. Holtappels, S. A. Abelson, et al. · Microbiology Spectrum · 8

Evolutionary Pressures Shape Undifferentiated Pleomorphic Sarcoma Development and Radiotherapy Response

2025 · Erik S. Blomain, Shaghayegh Soudi, et al. · Cancer Research · 7

Distinct Sarcoma Microenvironments Predict Benefit from Addition of Pembrolizumab to Preoperative Radiotherapy and Surgery in SU2C-SARC032

2025 · Stefano Testa, Jonathon E. Himes, et al. · medRxiv · 1

Personalized Circulating Tumor DNA Analysis for Predicting Outcomes and Tracking Response to Radiotherapy and Pembrolizumab in Localized Sarcomas: Analysis of the SU2C-SARC032 Trial

2026 · Ajay Subramanian, Serey C.L. Nouth, et al. · Journal of Clinical Oncology

Whole genome-based circulating tumor DNA analysis as an ultrasensitive biomarker in pediatric sarcomas.

2025 · Claire Johns, Ajay Subramanian, et al. · Journal of Clinical Oncology

Supplementary Figures and Methods from Evolutionary Pressures Shape Undifferentiated Pleomorphic Sarcoma Development and Radiotherapy Response

2025 · Erik S. Blomain, Shaghayegh Soudi, et al.

Supplementary Tables from Evolutionary Pressures Shape Undifferentiated Pleomorphic Sarcoma Development and Radiotherapy Response

2025 · Erik S. Blomain, Shaghayegh Soudi, et al.

Data from Evolutionary Pressures Shape Undifferentiated Pleomorphic Sarcoma Development and Radiotherapy Response

2025 · Erik S. Blomain, Shaghayegh Soudi, et al.

Works count: 8

Citation count: 16

H-index: 2

I10-index: